OECD Working Group on Good Laboratory Practice. Template for submission of comments on draft GLP Guidance Documents. Instructions for Use

Size: px
Start display at page:

Download "OECD Working Group on Good Laboratory Practice. Template for submission of comments on draft GLP Guidance Documents. Instructions for Use"

Transcription

1 OECD Working Group on Good Laboratory Practice Template for submission of comments on draft GLP Guidance Documents Instructions for Use 1. First, please complete the table below giving the full name of the draft document and your name and contact details. Comments received without the identity of the submitter may not be considered by the Working Group. Full Name of Document: OECD DRAFT ADVISORY DOCUMENT 16: THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS (Draft OECD Guidance Document, 16 September 2014) Submitter s Name: Greg Furrow Position in Organisation: President Organisation / Affiliation: Society of Quality Assurance Address 154 Hansen Road, Suite 201, Charlottesville, VA USA Country / Economy USA (United States of America) Greg.Furrow@wilresearch.com; michael.regehr@basf.com Date: 14 NOV Second, insert your comments into the template attached using the following instructions: (i) Go into the header of the template and enter the full name of the document. This will ensure this critical information appears on each page. (ii) Column 1: Please enter a commonly accepted two or three letter abbreviation code for your country or economy. Do this for each comment. This information is critical for the Working Group to collate and review comments and to assist in identifying the source of the comment. (iii) Column 2: Please enter the line number (or paragraph number and line number within the paragraph, depending on how the document is presented) of the text you wish to comment on. (iv) Column 3: Please include your comment (including the affected text if appropriate), along with any justification. (v) Column 4: Please indicate what change you would like to make to the text as a result of your comment. Where relevant, please provide any proposed new wording. (vi) Column 5: This is for OECD WG use only. 3. Finally, once completed, please forward your comments to the appropriate authority (see Instructions) Thank you for your contribution to the work of the OECD Working Group on Good Laboratory Practice. 4 July 2014

2 . / USA 11 Please reference PIC/S and Red Apple II for both prospective and retrospective validations. Change Guidance for the validation of legacy systems is given by PIC/S PI 11-3 Good Practices for Computerised Systems in Regulated GxP Environments [effective ]. USA 16 Please match wording to paragraph 34 and Table 1 (page 21). To Guidance for the validation of computerised systems is given by PIC/S PI 11-3 Good Practices for Computerised Systems in Regulated GxP Environments [effective ] and Computerized Systems used in Nonclinical Safety Assessment: Current Concepts in Validation and Compliance [published 2008, DIA, Red Apple II ]. Change Management of a test facility To Test Facility Management USA 17/1 Study Directors and QA personnel may not be involved in each specific validation procedures. This is generally the responsibility of the system owner and designated support personnel. USA 18 Please reword to better define fully aware of the involvement. Change in any validation-relevant tasks To in the overall validation program Change The Study Directors should be fully aware of the involvement of any computerised system used in studies under their direction. Study Directors have the responsibility to ensure that computerised systems used in their studies are validated. To Study Directors have the responsibility to ensure that any and all computerised systems used in their studies are validated and used appropriately. USA 19 Please expand on the term specialist techniques. Change Quality Assurance personnel should be given training in any specialist techniques necessary. To Quality Assurance personnel should be given training in any special computer processes needed (system user training, audit trail reviewing, data analysis techniques, etc). USA 19 Please clarify read-only access to the data. Change Quality Assurance personnel should have, for data review, direct read-only access to the data stored within a computerised system. To During data review, Quality Assurance personnel should have direct read-only access to the data if only available within a computerised system. page 2 of 6

3 . / USA 20 Study Directors and QA personnel may not be involved in each specific validation procedures. This is generally the responsibility of the system owner and designated support personnel. USA 20, et al Please standardize spelling of computerised. See also paragraphs 40, 46, 50, 51. USA 21 Unless computer system technical standards are to be recognized, this should be more general. See also Table 2 Glossary. USA 28 Third-parties agreement may exist with the enterprise as a whole, rather than the GLP test facility alone. Formal agreements would be written agreement (as in paragraph 30). Please use just one term written agreement. Change understand their relevant procedures To understand the relevant procedures Change in any validation-relevant tasks To in the overall validation program Change computerized To computerised Change recognized technical standards To best practice guidances and standards Change formal agreements must exist between the GLP facility and any third parties To written agreements must exist for any third-party support of a GLP facility USA 31/5 Please clarify validation system. Change his quality assurance / risk manage-ment / validation system To quality assurance and validation procedures USA 38 Please use common format. See paragraph 39, 94. USA 39 Excellent common example. Minor wording enhancements are suggested to distinguish the spreadsheet from the COTS product. Change should be evaluated by the facility s validation system To should be reviewed as part of the facility s validation procedures Change "spread-sheet" To spreadsheet Change Spreadsheet templates for calculations using predefined formulas or self-written code should be regarded as an in-house developed application. As the qualification of the underlying COTS product has no relevance for the application, validation and documentation according chapter 2 and 3 is required. To Each spreadsheet template for calculations using pre-defined formulas, self-written equations, or macros should be validated and documented as an in-house developed application according chapters 2 and 3. Qualification of the underlying COTS product alone is not sufficient. page 3 of 6

4 . / USA 46 Please use English in place of Latin. Change inter alia to among other things USA 47 Source code may not be available to the regulated user for some COTS. The primary concern should be for limited-use or bespoke applications. See also Paragraph 75. USA 49(e) System performance can be assessed by evaluating the ongoing operations (live data transfers, user access) and may include new testing (example data processing, stress conditions). USA 54/2 Please specify that system inventory need not include each non-glp systems in addition to the GLP-relevant systems. Detailed inventory of all non-glp lab equipment, scales, calculators, cash registers, ATMs, laptops, VoIP phones, and smartphones would be a large and unproductive task. Change Some OECD Member countries require that the source code for application software should be available at, or retrievable to, the test facility. To Source code of bespoke systems (or all application software in some OECD Member countries) should be retrievable by the regulated user to provide the monitoring authority access to the software code. This can be done by archiving a digital copy of the source code, escrow arrangements, or service level agreements. Change periodic testing To periodic evaluation Change The list should cover non-glp-relevant systems as well To The regulated user should also describe general machine types, software, or uses that are non-glp-relevant systems USA 67 Please match wording to paragraph 56. Change retrospectively validated systems To retrospectively evaluated systems USA 69 Please use the common reference format. Change ISO/9001 To ISO 9001 USA 75 Source code may not be available to the regulated user for some COTS. The primary concern should be for limited-use or bespoke applications. See also paragraph 47. To USA 77 Please specify that a supplier s IQ/OQ activities and documentation can supplement or replace testing by the regulated user as expressed in GAMP5. Change Source code of bespoke systems should be retrievable by the regulated user to provide the monitoring authority access to the software code. Source code of bespoke systems should be retrievable by the regulated user to provide the monitoring authority access to the software code. This can be done by archiving a digital copy of the source code, escrow arrangements, or service level agreements. Change All systems, including purchased systems (e.g. an HPLC system), need to be tested and evaluated by the regulated user. To The regulated user must ensure all systems, including purchased systems (e.g. an HPLC system), are tested and evaluated. A supplier s IQ/OQ activities and documentation may supplement or replace testing by the regulated user. page 4 of 6

5 . / USA 84/2-3 Suggest maintaining the language found in EU GMP Annex 11. Change "meaningfulness" To value and/or meaning USA 87 Please use common format. See paragraph 39, 94. Change " spread sheets " To spreadsheets USA 102/2-3 The raw data respecting the histopathological evaluation of a study is the signed dated pathologist report. Notes created by a pathologist during the histopathological evaluation of a study are not raw data. USA 105 Printing some original raw data in a human-readable format (which is the perceived goal) is problematic or futile because of proprietary storage formats. Data integrity and audit accessibility are important. USA 106 Only printouts created after the data modification can reflect the change. Printouts from a computerised system may also reflect an independent audit trail as explained in paragraph 111. USA Suggest use of Audit Trail to distinguish from a QAU activity of auditing. Remove written observations and conclusions as written by a pathologist, Change print all electronic records (including raw data and derived data) To print or otherwise provide human-readable copies of all electronic records (as raw data or derived reports, as appropriate for data integrity and auditing) Change in printed copies. To in later printed copies. Audit trails may exist in some systems as a record of changes independent of the view to the data (on screen or printed). Change The regulated user should audit To The regulated user should audit trail Change If audit policies for the application To If audit trailing policies for the application USA 115, 118 Suggest the term validated in place of valid. Change valid status of the system To validated status of the system USA 116 Suggested language for clarification and addition of configuration management. USA 141/3-5 Overall responsibility would be on the regulated user (test facility management delegating to the system owner), and uncertain of the task for each role listed. Change should be within the system description and need not be part of change management To need not be part of formal change or configuration management if properly explained in the system description Change Facility management, study director and quality assurance To The regulated user page 5 of 6

6 . / USA Please rephrase to clarify release of data is not a new requirement in GLP. USA 166/2 Software backup copies may not be provided to the regulated user from all vendors. USA Table 1: Regulated User USA Table 2: Recognised Technical Standards Responsibilities are delegated by Test Facility Management to the appropriate staff. Unless computer system technical standards are to be recognized specifically, this should remain more general. See also paragraph 21. Change Electronic release of data should be performed using an electronic signature. The electronic data approval / release process should be documented in detail. To If a procedure includes an electronic data approval / release process, it should be documented in detail and performed using an electronic signature. Change maintained To maintained, escrowed, or available by service level agreement. Change represented by the test facility management. To represented by the Test Facility Management, will delegated duties to System Owners, IT Personnel, Validation Directors, Study Directors, and Quality Assurance. Remove entry for Recognized technical standards page 6 of 6

GLP Computerized Systems Updates from OECD Guidance. Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando

GLP Computerized Systems Updates from OECD Guidance. Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando GLP Computerized Systems Updates from OECD Guidance Dr. Michael Regehr, BASF Corporation 28 JAN 2016, NAICC, Orlando 1 Validation EPA GLP Obligation Expectations of the EPA for Computers in GLP (40 CFR

More information

MASTER VALIDATION PLAN PROCEDURE DRAFT DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE

MASTER VALIDATION PLAN PROCEDURE DRAFT DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE DRAFT OF A POSSIBLE COMPUTER SYSTEMS VALIDATION MASTER PLAN PROCEDURE 1. PURPOSE The purpose of this SOP is to define the minimum requirements for Computer Systems Validation (CSV) at (insert name of company

More information

Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY TO and

Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY  TO and 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org 31 October 2008 Enterprise and Industry Directorate-General European Commission B-1049 Brussels Belgium BY EMAIL TO entr-gmp@ec.europa.eu

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 08 April 2008 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU

More information

EU Annex 11 update. An ISPE interpretation

EU Annex 11 update. An ISPE interpretation EU Annex 11 update An ISPE interpretation ISPE Interpretation Published by Winnie Cappucci Chris Clark Tim Goossens Sion Wyn Disclaimer ISPE cannot ensure and does not warrant that computerized systems

More information

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011

EU Annex 11 US FDA 211, 820, 11; other guidelines Orlando López 11-MAY-2011 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008)

EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008) EU GMP - Annex 11 Computerised systems Versione corrente Nuova versione per commenti (emessa 8 aprile 2008) Principle The introduction of computerised systems into systems of manufacturing, including storage,

More information

COMPUTERISED SYSTEMS

COMPUTERISED SYSTEMS ANNEX 11 COMPUTERISED SYSTEMS PRINCIPLE This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components

More information

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR

EU Annex 11 US FDA , (g), (i), 11 Orlando López 09-APR Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11.

References Concept. Principle. EU Annex 11 US FDA , (g), (i), 11 Orlando Lopez 2/15/11. Old Annex 11. References Concept Principle a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which

More information

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide.

Computerised Systems. Alfred Hunt Inspector. Wholesale Distribution Information Day, 28 th September Date Insert on Master Slide. Computerised Systems Wholesale Distribution Information Day, Alfred Hunt Inspector Date Insert on Master Slide Slide 1 Index What is a computerised system Updates to EU GDPs Expectations Case studies Slide

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064599 EudraLex The Rules Governing Medicinal Products

More information

Computerised Systems. Inspection Expectations. Paul Moody, Inspector. 18/10/2013 Slide 1. ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013

Computerised Systems. Inspection Expectations. Paul Moody, Inspector. 18/10/2013 Slide 1. ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013 Computerised Systems Inspection Expectations ISPE GAMP COP Ireland Meeting, Dublin, 17 th October 2013 Paul Moody, Inspector Slide 1 Presentation Contents Brief Introduction to the IMB Regulatory References

More information

Computer System Validation Perform a Gap Analysis of your CSV Processes

Computer System Validation Perform a Gap Analysis of your CSV Processes Computer System Validation Perform a Gap Analysis of your CSV Processes Chris Wubbolt, QACV Consulting Computer and Software Validation Conference April 27, 2017 www.qacvconsulting.com 1 Objectives Computer

More information

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0)

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0) Regulatory Overview Annex 11 and Part 11 Sion Wyn Conformity +[44] (0) 1492 642622 sion.wyn@conform-it.com 1 Two Key Regulations Annex 11 21 CFR Part 11 Apply to the regulated company, but often have a

More information

Summary of Significant Changes. Policy

Summary of Significant Changes. Policy This Policy replaces POL251/1 Copy Number Effective 03/04/17 Summary of Significant Changes Addition of requirements of 2016 review of Guidance by MHRA, ALCOA+, and documents related to Policy The purpose

More information

PART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES

PART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES Part 58-explanation of changes Scope ( 58.1) We propose to expand the scope of FDA-regulated nonclinical laboratory studies to specifically include toxicity studies. For purposes of this proposal, toxicity

More information

PART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES

PART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES Part 58-explanation of changes Scope ( 58.1) We propose to expand the scope of FDA-regulated nonclinical laboratory studies to specifically include toxicity studies. For purposes of this proposal, toxicity

More information

SPAQA GLP Monitoring Authority Roundtable 2017

SPAQA GLP Monitoring Authority Roundtable 2017 General Questions 1. Information flow Would it be possible for the GLP notification office to inform SPAQA (vorstand@spaqa.ch) of changes to the Swiss Monitoring Authorities website (e.g. new OECD guidelines,

More information

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT

General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT General European OMCL Network (GEON) QUALITY MANAGEMENT DOCUMENT PA/PH/OMCL (08) 69 R7 VALIDATION OF COMPUTERISED SYSTEMS CORE DOCUMENT Full document title and reference Document type Validation of Computerised

More information

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER 7 2016 TUUSULA FINLAND Timo Kuosmanen STERIS Finn-Aqua Timo_Kuosmanen@steris.com AUDIT TRAIL IN CRITICAL UTILITIES MONITORING CURRENT TRENDS CONTENTS BACKGROUND

More information

Computerised System Validation

Computerised System Validation Computerised System Validation Considerations for the Validation Lifecycle Paul Moody GMP Conference 12 th November 2014 Regulatory References EU GMP Annex 11 (2011) http://ec.europa.eu/health/files/eudralex/vol-4/annex11_01-2011_en.pdf

More information

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU Numerous articles are available comparing the current and previous EU Code of GMP Chapter 4: Documentation, but no comparison exists between

More information

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

1201 Maryland Avenue SW, Suite 900, Washington, DC , 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org February 22, 2011 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,

More information

Swiss Interpretation of the GLP Principles 2017 State: June 13, 2017

Swiss Interpretation of the GLP Principles 2017 State: June 13, 2017 Swiss Agency for Therapeutic Products Swiss Interpretation of the GLP Principles 2017 State: June 13, 2017 This document contains joint guidelines for the interpretation of GLP Principles according to

More information

Good Laboratory Practice GUIDELINES FOR THE VALIDATION OF COMPUTERISED SYSTEMS. Release Date:

Good Laboratory Practice GUIDELINES FOR THE VALIDATION OF COMPUTERISED SYSTEMS. Release Date: AGIT: Swiss Working Group on Information Technology in a GLP Environment Good Laboratory Practice GUIDELINES FOR THE VALIDATION OF COMPUTERISED SYSTEMS Release Date: 31.01.2018 Version: 3.0 TABLE OF CONTENTS

More information

Regulations in Pharmaceutical Laboratories

Regulations in Pharmaceutical Laboratories Regulations in Pharmaceutical Laboratories February 2004 Ludwig Huber Compliance Fellow for Life Sciences and Chemical Analysis Chairperson: Rob Sample Regulations and Quality Standards Developed by Industries

More information

LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY:

LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY: LEVERAGING YOUR VENDORS TO SUPPORT DATA INTEGRITY: QUESTIONS TO ASK AND RESPONSIBILITIES TO DOCUMENT Heather Longden Boston Chapter Educational Meeting April 2018 About Waters Lab Informatics Separations

More information

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS GLOBAL PROVIDER, LOCAL SOLUTIONS IN YOUR LANGUAGE DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS Francesco Amorosi PhD Octorber 2017 DATA INTEGRITY & CSV:

More information

The Role of the LMS in 21 CFR Part 11 Compliance

The Role of the LMS in 21 CFR Part 11 Compliance The Role of the LMS in 21 CFR Part 11 Compliance Co-author: Dr. Bob McDowall, Director R.D. McDowall Limited ABSTRACT The purpose of this white paper is to describe how NetDimensions Learning addresses

More information

Data Integrity. Requirements for a GMP-compliant Data Life Cycle SPEAKERS: May 2017, Budapest, Hungary LEARNING OBJECTIVES:

Data Integrity. Requirements for a GMP-compliant Data Life Cycle SPEAKERS: May 2017, Budapest, Hungary LEARNING OBJECTIVES: Data Integrity Requirements for a GMP-compliant Data Life Cycle All participants get a free copy of the current version of the ECA Data Governance and Data Integrity for GMP Regulated Facilities Guidance

More information

Risk-based Approach to Part 11 and GxP Compliance

Risk-based Approach to Part 11 and GxP Compliance Welcome to our E-Seminar: Risk-based Approach to Part 11 and GxP Compliance 1 Intro Common Discussion Q: Do I really need to do this? Possible Answers A: Of course! (QA) B: Who cares, I have work to do!

More information

Audit Trail Review / Data Integrity

Audit Trail Review / Data Integrity Audit Trail Review / Data Integrity Requirements for a GMP-compliant Data Life Cycle Comments on the FDA Draft Guidance for Industry Data Integrity and Compliance with cgmp and on the new GAMP Records

More information

á1058ñ ANALYTICAL INSTRUMENT QUALIFICATION

á1058ñ ANALYTICAL INSTRUMENT QUALIFICATION USP 41 General Information / á1058ñ 1 á1058ñ ANALYTICAL INSTRUMENT QUALIFICATION INTRODUCTION A large variety of analytical instruments, ranging from a simple apparatus to complex computerized systems,

More information

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT August 2010 RESTRICTED PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT Please address any comments on this draft guideline

More information

Data Integrity Through the Life Cycle Balancing Quality and Innovation. Sion Wyn Conformity +44 (0)

Data Integrity Through the Life Cycle Balancing Quality and Innovation. Sion Wyn Conformity +44 (0) Data Integrity Through the Life Cycle Balancing Quality and Innovation Sion Wyn Conformity +44 (0) 1492 642622 sion.wyn@conform-it.com Theme Achieving harmony Balancing quality, safety, and compliance

More information

Oracle Tech Cloud GxP Position Paper December, 2016

Oracle Tech Cloud GxP Position Paper December, 2016 Oracle Tech Cloud GxP Position Paper Page 1 of 29 Oracle Tech Cloud GxP Position Paper December, 2016 Prepared By: Subbu Viswanathan, Head of Solutions Reviewed By: David Blewitt, VP Cloud Compliance Oracle

More information

GOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS

GOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 011-2 1 July 2004 PIC/S GUIDANCE GOOD PRACTICES FOR COMPUTERISED SYSTEMS IN REGULATED GXP ENVIRONMENTS PIC/S July 2004

More information

Data Integrity: Production Environment

Data Integrity: Production Environment Data Integrity: Production Environment MANUAL AND AUTOMATED SYSTEMS Ciara Turley GMP Conference 12 th November 2014 Content GMP Guide requirements and application to processing equipment Security Audit

More information

for Data Integrity Requirements for a GMP-compliant Data Life Cycle With an optional full-day pre-course session Audit Trail Review SPEAKERS:

for Data Integrity Requirements for a GMP-compliant Data Life Cycle With an optional full-day pre-course session Audit Trail Review SPEAKERS: Data Integrity Requirements for a GMP-compliant Data Life Cycle With an optional full-day pre-course session Audit Trail Review SPEAKERS: Bob McDowall R.D. McDowall Ltd. Karl-Heinz Menges Regierungspräsidium

More information

GAMP Guideline & Validation Documentation

GAMP Guideline & Validation Documentation GAMP Guideline & Validation Documentation Danilo Maruccia Milano, 21 Marzo 2006 GAMP Guideline & Validation Documentation GAMP Guideline Planning documents Specification Documents Testing Documents Acceptance

More information

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev22APR16

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev22APR16 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

COMPUTERIZED SYSTEM VALIDATION

COMPUTERIZED SYSTEM VALIDATION www.kevintech.com Current Practices of COMPUTERIZED SYSTEM VALIDATION Kevin ISSUE.1/2017 CONNECT INSIDE - Basics of Computerized System Validation - Life Cycle of Computerized System The less manual the

More information

SIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2

SIMATIC IT. SIMATIC IT R&D SUITE V7.1 Compliance Response ERES. Introduction 1. The Requirements in Short 2 Introduction 1 The Requirements in Short 2 SIMATIC IT Meeting the Requirements with SIMATIC IT R&D Suite V7.1 3 SIMATIC IT R&D SUITE V7.1 Evaluation List for SIMATIC IT R&D Suite V7.1 4 Product Information

More information

Develop a Roadmap for the Implementation of a Global CSV Program. Eileen Cortes April 26, 2017

Develop a Roadmap for the Implementation of a Global CSV Program. Eileen Cortes April 26, 2017 Develop a Roadmap for the Implementation of a Global CSV Program Eileen Cortes April 26, 2017 Agenda CSV Regulation Principles CSV Lifecycle Approach CSV and Quality Management Governance Program and CSV

More information

Data Integrity. Requirements for a GMP-compliant Data Life Cycle SPEAKERS: August 2017, Copenhagen, Denmark LEARNING OBJECTIVES:

Data Integrity. Requirements for a GMP-compliant Data Life Cycle SPEAKERS: August 2017, Copenhagen, Denmark LEARNING OBJECTIVES: Data Integrity Requirements for a GMP-compliant Data Life Cycle All participants get a free copy of the current version of the ECA Data Governance and Data Integrity for GMP Regulated Facilities Guidance

More information

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev05MAR15

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev05MAR15 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Lab Data Integrity. Meeting FDA & EU Concerns. Part 1: Establishing the Controls for Ensuring Laboratory Data Integrity

Lab Data Integrity. Meeting FDA & EU Concerns. Part 1: Establishing the Controls for Ensuring Laboratory Data Integrity Lab Data Integrity Meeting FDA & EU Concerns All participants get a free copy of the current version of the ECA Data Governance and Data Integrity for GMP Regulated Facilities Guidance SPEAKERS: Dr Christopher

More information

Latino America Consultores Innovation & Technology to make your Business Compliant

Latino America Consultores Innovation & Technology to make your Business Compliant Latino America Consultores Innovation & Technology to make your Business Compliant Annex 15 & EMA Process Validation Guide Line 1 Changes in Requirements The Pharmaceutical Industry has adapted its business

More information

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev11AUG16

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev11AUG16 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev19Dec14

Cross-walk between EU Annex 11 and US FDA 211, 820, 11; other guidelines and regulations Orlando López Rev19Dec14 Principle. a. This annex applies to all forms of computerised systems used as part of a GMP regulated activities. A computerised system is a set of software and hardware components which together fulfill

More information

Regulatory Expectations, Standards & Guidelines

Regulatory Expectations, Standards & Guidelines Regulatory Expectations, Standards & Guidelines Regulatory Requirements Pharmacopeias Good Automated Manufacturing Practice (GAMP) 21 CFR Part 11 and Annex 11 Consequences of Non-Compliance 22 Regulatory

More information

please fill out here:

please fill out here: If the bill-to-address deviates from the specifications on the right, please fill out here: Reservation Form (Please complete in full) Data Integrity Requirements for a GMP-compliant Data Life Cycle 10

More information

Preparing for a Software Quality Audit

Preparing for a Software Quality Audit Preparing for a Software Quality Audit By Praxis Life Sciences 1925 West Field Court, Suite 125, Lake Forest, IL 60045 praxislifesciences.com +1(847) 295-7160 validationcenter.com Preparing for a Software

More information

Ensure Data Integrity Compliance Enterprise-Wide

Ensure Data Integrity Compliance Enterprise-Wide Ensure Data Integrity Compliance Enterprise-Wide PharmaQual 360 º Conference February 24, 2017 Chris Wubbolt QACV Consulting, LLC www.qacvconsulting.com 1 Objectives What is data integrity and the definition

More information

Current quality status of CABETs environmental laboratory and necessary steps to meet GLP requirements

Current quality status of CABETs environmental laboratory and necessary steps to meet GLP requirements Current quality status of CABETs environmental laboratory and necessary steps to meet GLP requirements June 18 22, 2007 Paul de Bie (Alterra) Jiang Hui (ICAMA) Workshop Report WP1 1 Beijing / Wageningen,

More information

Good Laboratory Practice CHANGE MANAGEMENT AND RISK ASSESSMENT OF VALIDATED COMPUTERISED SYSTEMS IN A GLP ENVIRONMENT. Release Date:

Good Laboratory Practice CHANGE MANAGEMENT AND RISK ASSESSMENT OF VALIDATED COMPUTERISED SYSTEMS IN A GLP ENVIRONMENT. Release Date: AGIT: Swiss Working Group on Information Technology in a GLP Environment Good Laboratory Practice CHANGE MANAGEMENT AND RISK ASSESSMENT OF VALIDATED COMPUTERISED SYSTEMS IN A GLP ENVIRONMENT Release Date:

More information

Curriculum Vitae Dr. Joachim Schoch-Bösken. jsb-validierung Zwischen den Bächen 9 D Rheinfelden

Curriculum Vitae Dr. Joachim Schoch-Bösken. jsb-validierung Zwischen den Bächen 9 D Rheinfelden Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 176 42 60 85 72 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de

More information

Use of computerised equipment, software and systems in clinical research

Use of computerised equipment, software and systems in clinical research Standard Operating Procedures (SOP) for: Use of computerised equipment, software and systems in clinical research SOP Number: 38a Version Number: 1.0 Effective Date: 21/3/16 Review Date: 21/8/17 Author:

More information

PACIFIC RIM CONSULTING COMMENTS ON FDA PROPOSAL TO REVISE GLPS

PACIFIC RIM CONSULTING COMMENTS ON FDA PROPOSAL TO REVISE GLPS PACIFIC RIM CONSULTING COMMENTS ON FDA PROPOSAL TO REVISE GLPS 1. GLP Quality System While many of the requirements of the existing regulation are consistent with a GLP quality system, FDA believes that

More information

Current Trends in Data Quality and Integrity Issues in Inspections and Risk Based Approach to Investigations; EU perspective

Current Trends in Data Quality and Integrity Issues in Inspections and Risk Based Approach to Investigations; EU perspective Current Trends in Data Quality and Integrity Issues in Inspections and Risk Based Approach to Investigations; EU perspective Mark Birse / Richard Andrews, MHRA Data Integrity has no relationship with product

More information

Data Integrity Why is it important? DADM Conference - 22 August 2017

Data Integrity Why is it important? DADM Conference - 22 August 2017 Data Integrity Why is it important? DADM Conference - 22 August 2017 Maibritt Haugaard Møller, System Validation Expert Mette Ravn, Vice President, Data Management, IT and System Validation Overview of

More information

Paperless recorders and 21 CFR part 11 compliance Videographic recorders

Paperless recorders and 21 CFR part 11 compliance Videographic recorders Sales guide SG/RandC/002 EN Paperless recorders and 21 CFR part 11 compliance Videographic recorders Introduction Today's manufacturing environment is becoming more regulated than ever and the most well

More information

SESSION 14. Documentation Requirements and Management for Validation. 30 March Frits Vogt

SESSION 14. Documentation Requirements and Management for Validation. 30 March Frits Vogt Validation Services SESSION 14 Documentation Requirements and Management for Validation 30 March 2017 Frits Vogt fritsvogt@valserv.nl Content Documentation Requirements and Management for Validation I.

More information

System Requirements (URS)

System Requirements (URS) System s (URS) System Document Control System Document ID URS000XXX Version 1 DOCUMENT APPROVALS Reason For Signature Name Position Signature Date Prepared by Vic Johnson Project Manager Checked for accuracy

More information

Requirements for a GMP-compliant Data Life Cycle May 2016, Berlin, Germany. Karl-Heinz Menges Regierungspräsidium Darmstadt

Requirements for a GMP-compliant Data Life Cycle May 2016, Berlin, Germany. Karl-Heinz Menges Regierungspräsidium Darmstadt Data Integrity Workshops on: Analysis of FDA Warning Letters Key Data Integrity Topics / Criteria Assessing a System for Data Integrity Requirements for a GMP-compliant Data Life Cycle 17-19 May 2016,

More information

Strategies for Risk Based Validation of Laboratory Systems

Strategies for Risk Based Validation of Laboratory Systems Strategies for Risk Based Validation of Laboratory Systems Video Web Seminar September 23, 2004 Ludwig Huber E-mail: ludwig_huber@agilent.com Today s Agenda Background information: why risk assessment,

More information

Regulations and guidance for the pharmaceutical industry

Regulations and guidance for the pharmaceutical industry w w w. spec troscopyonline. com April 2011 Spectroscopy 26(4) 1 Focus on Quality Is GMP Annex 11 Europe s Answer to 21 CFR 11? January 2011 saw the publication of the new revision of European Union (EU)

More information

Contents. Contents (13) 1 Qualification (21)

Contents. Contents (13) 1 Qualification (21) 1 Qualification (21) 1.A Official requirements (23) 1.A.1 Legal aspects of qualification (23) 1.A.2 Documentation of the qualification (26) 1.A.3 Design Qualification (DQ) (27) 1.A.4 Installation Qualification

More information

GOOD LABORATORY PRACTICE (GLP)

GOOD LABORATORY PRACTICE (GLP) GOOD LABORATORY PRACTICE (GLP) Series Catalog CITI Program s GLP series provides an overview of how nonclinical laboratory studies should be planned, performed, monitored, recorded, reported, and archived

More information

Good Laboratory Practice. GUIDELINES FOR THE MANAGEMENT OF ELECTRONIC STANDARD OPERATING PROCEDURES (SOPs) IN A GLP ENVIRONMENT

Good Laboratory Practice. GUIDELINES FOR THE MANAGEMENT OF ELECTRONIC STANDARD OPERATING PROCEDURES (SOPs) IN A GLP ENVIRONMENT AGIT: Swiss Working Group on Information Technology in a GLP Environment Good Laboratory Practice GUIDELINES FOR THE MANAGEMENT OF ELECTRONIC STANDARD OPERATING PROCEDURES (SOPs) IN A GLP ENVIRONMENT Release

More information

Establishing the Self Inspections and Controls for Ensuring Audits to Confirm Effective Laboratory Data Integrity, Data Integrity Controls,

Establishing the Self Inspections and Controls for Ensuring Audits to Confirm Effective Laboratory Data Integrity, Data Integrity Controls, Lab Data Integrity Meeting FDA & EU Concerns SPEAKERS: Dr Christopher Burgess Chairman of the ECA Analytical Quality Control Working Group Dr Bob McDowall Member of the ECA IT Compliance Interest Group

More information

Validation Documentation. Presented by John Montalto 27 March, 2013

Validation Documentation. Presented by John Montalto 27 March, 2013 Validation Documentation Presented by John Montalto 27 March, 2013 Validation planning Validation policies define management intent and commitment Validation Master Plans (VMPs) Individual Validation Plans

More information

21 CFR Part 11 Compliance for SaaS/Cloud Applications

21 CFR Part 11 Compliance for SaaS/Cloud Applications 21 CFR Part 11 Compliance for SaaS/Cloud Applications *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! This highly interactive two-day course uses real life examples and explores

More information

Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR

Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! This highly interactive two-day course uses

More information

Subject: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification and Validation

Subject: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification and Validation 29 May 2014 EUROPEAN COMMISSION Health and Consumers Directorate-General Subject: EU Guidelines for Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 15: Qualification

More information

Library Guide: Active Pharmaceutical

Library Guide: Active Pharmaceutical Library Guide: Active Pharmaceutical Ingredients (API) Table of Contents Overview...3 Sample Curriculum...5 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)...7 A Tour of the

More information

Effective Management and Operations of GXP Laboratories

Effective Management and Operations of GXP Laboratories Effective Management and Operations of GXP Laboratories Course Objective: Upon completion of this course, attendees involved in establishing and assuring that Good Laboratory / Good Manufacturing Practice

More information

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4 EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Ref. Ares(2015)4234460-12/10/2015 Medicinal products quality, safety and efficacy Brussels, 12 October 2015 EudraLex Volume 4 EU Guidelines

More information

Good Distribution Practices Toolkit Change Control 10 March 2016

Good Distribution Practices Toolkit Change Control 10 March 2016 Good Distribution Practices Toolkit Change Control 10 March 2016 1 Disclaimer The content of this presentation were derived mainly from WHO training material on Change Control and edited to suit the Distributor

More information

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice

Working Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 Working

More information

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE

GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS FOR HUMAN USE PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 047-1 Annex 1 July 2018 GUIDELINES ON THE PRINCIPLES OF GOOD DISTRIBUTION PRACTICE OF ACTIVE SUBSTANCES FOR MEDICINAL

More information

Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation

Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation Clarity CDS since version 7.2 supportive tools for compliance with Title 21 CFR Part 11, EudraLex Chapter 4, Annex 11 and other similar legislation Datasheet Introduction US Part 11 in Title 21 of Code

More information

GAMP5 Validation for Dynamics 365

GAMP5 Validation for Dynamics 365 GAMP5 Validation for Dynamics 365 Prepared by: Michael Webster, Business Development Director, RSM US LLP michael.webster@rsmus.com, +1 617 241 1544 Dynamics 365 is an ideal enterprise resource planning

More information

Validation of Commercial Computerised Systems using a Single Life Cycle Document (Integrated Validation Document)

Validation of Commercial Computerised Systems using a Single Life Cycle Document (Integrated Validation Document) Validation of Commercial Computerised Systems using a Single Life Cycle Document (Integrated Validation Document) R. D. McDowall McDowall Consulting, 73 Murray Avenue, Bromley, Kent, BR1 3DJ, UK Summary

More information

PRINCE2 - Quality Management Strategy

PRINCE2 - Quality Management Strategy Created/updated 05/11/17 PRINCE2 - Quality Management Strategy Downloaded from stakeholdermap.com. Visit Prince2 Templates for more Prince2 downloads. Get a Mind Map Quality Management Strategy template

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Medicinal Products Quality, Safety and Efficacy Brussels, 6 February 2014 SANCO/TSE/ The received contributions together with the identity of

More information

INFS 214: Introduction to Computing

INFS 214: Introduction to Computing INFS 214: Introduction to Computing Session 8 Application Software Lecturer: Dr. Ebenezer Ankrah, Dept. of Information Studies Contact Information: eankrah@ug.edu.gh College of Education School of Continuing

More information

Outsourcing - managing risks and opportunities over which you now have less control

Outsourcing - managing risks and opportunities over which you now have less control Outsourcing - managing risks and opportunities over which you now have less control Kevin O Donnell, PhD PDA Meeting, Dublin 22 nd November 2018 Slide 2 Typical Examples The key GMP Requirements & Guidance

More information

Computer. Systems Validation. Full Time Part Time Online.

Computer. Systems Validation. Full Time Part Time Online. Computer Systems Validation Full Time Part Time Online www.dpseng.com.sg Contents 1. Welcome 2. Programme Overview 3. Programme Content www.dpseng.com.sg 2 Welcome Transition into a new career in the Pharmaceutical

More information

Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1

Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1 Compliance Response Electronic Records / Electronic Signatures (ERES) for SIMATIC PCS 7 V8.1 SIEMENS AG Industry Sector VSS Pharma D-76187 Karlsruhe, Germany E-Mail: pharma@siemens.com March 2015 A5E35829023-AA

More information

EHR Site Visit Questionnaire

EHR Site Visit Questionnaire HIM 3014 Health Information Technology Practicum EHR Assessment - Site Visit Questionnaire Student Name: Instructions: Schedule an EHR site visit and complete the following questionnaire by the date found

More information

Introduction to 21 CFR 11 - Good Electronic Records Management

Introduction to 21 CFR 11 - Good Electronic Records Management INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY Review Article Introduction to 21 CFR 11 - Good Electronic Records Management Pal Tapas Kumar* and Maity Subhasis NSHM Knowledge Campus,

More information

Data Integrity Compliance Project

Data Integrity Compliance Project Data Integrity Compliance Project RISK FACTORS FOR DI ISSUES Outsourcing Supply Chain Data Review Practices Increasing use of electronic systems Economic Stressors 2 Fully Integrated into QMS DATA INTEGRITY

More information

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION

(Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION 21.3.2015 EN Official Journal of the European Union C 95/1 II (Information) INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES EUROPEAN COMMISSION Guidelines of 19 March 2015 on

More information

U.S. Technical Advisory Group to ISO/Technical Committee 207 Clarification of Intent of ISO 14001

U.S. Technical Advisory Group to ISO/Technical Committee 207 Clarification of Intent of ISO 14001 Committee Correspondence US SUB-TAG to ISO/TC/207/SC1 on Environmental Management Systems Administrator: Jennifer Admussen, ASQ Chair: Susan L.K. Briggs When originating or replying, please send copy to

More information

Pharmaceutical cgmps for the 21st Century February 2004

Pharmaceutical cgmps for the 21st Century February 2004 Pharmaceutical cgmps for the 21st Century February 2004 Ludwig Huber Compliance Fellow for Life Sciences and Chemical Analysis Chairperson: Rob Sample FDA GxP Regulations Along the Drug Life Basic Research

More information

Harmonizing Manufacturing across Multiple Sites and Regions

Harmonizing Manufacturing across Multiple Sites and Regions Harmonizing Manufacturing across Multiple Sites and Regions ISCT North America Regional Meeting Philadelphia, Pennsylvania Byron T. McAllister B.T. McALLISTER ASSOCIATES, INC. Tuesday, 10 September 2013

More information

EIOPA Common Application Package For Internal Models: Explanatory Note

EIOPA Common Application Package For Internal Models: Explanatory Note November 2014 EIOPA Common Application Package For Internal Models: Explanatory Note 1. Introduction 1.1. EIOPA has published an Opinion 1 stating that National Competent Authorities ( NCAs ) should recommend

More information